134 related articles for article (PubMed ID: 35116880)
21. DLX4 as a prognostic marker for hepatocellular carcinoma.
Gao Y; Li Z; Guo X; Liu Y; Zhang K
Neoplasma; 2014; 61(3):318-23. PubMed ID: 24824934
[TBL] [Abstract][Full Text] [Related]
22. Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis.
Huang Y; Li LZ; Zhang CZ; Yi C; Liu LL; Zhou X; Xie GB; Cai MY; Li Y; Yun JP
J Transl Med; 2012 May; 10():106. PubMed ID: 22625427
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of RPS6KB1 predicts worse prognosis in primary HCC patients.
Li PD; Zhang WJ; Zhang MY; Yuan LJ; Cha YL; Ying XF; Wu G; Wang HY
Med Oncol; 2012 Dec; 29(5):3070-6. PubMed ID: 22684641
[TBL] [Abstract][Full Text] [Related]
24. Elevated CTSL2 expression is associated with an adverse prognosis in hepatocellular carcinoma.
Jing J; Wang S; Ma J; Yu L; Zhou H
Int J Clin Exp Pathol; 2018; 11(8):4035-4043. PubMed ID: 31949793
[TBL] [Abstract][Full Text] [Related]
25. Sperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis.
Zhou H; Wang SC; Ma JM; Yu LQ; Jing JS
Med Sci Monit; 2018 Aug; 24():6021-6028. PubMed ID: 30157168
[TBL] [Abstract][Full Text] [Related]
26. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
28. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
[TBL] [Abstract][Full Text] [Related]
29. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4.
Michaud JL; Lemieux LI; Dubé M; Vanderhyden BC; Robertson SJ; Kennedy CR
J Am Soc Nephrol; 2003 May; 14(5):1200-11. PubMed ID: 12707390
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of microRNA-32 is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma.
Yang H; Li Y; Zhong X; Luo P; Luo P; Sun R; Xie R; Fu D; Ma Y; Cong X; Li W
Oncol Lett; 2018 Apr; 15(4):4097-4104. PubMed ID: 29541175
[TBL] [Abstract][Full Text] [Related]
31. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
32. EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma.
Cha YL; Li PD; Yuan LJ; Zhang MY; Zhang YJ; Rao HL; Zhang HZ; Zheng XF; Wang HY
PLoS One; 2015; 10(2):e0117493. PubMed ID: 25658620
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients.
Zhao ZK; Yu HF; Wang DR; Dong P; Chen L; Wu WG; Ding WJ; Liu YB
World J Gastroenterol; 2012 Dec; 18(45):6651-6. PubMed ID: 23236241
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
[TBL] [Abstract][Full Text] [Related]
35. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C
Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949
[TBL] [Abstract][Full Text] [Related]
36. High expression of myofibrillogenesis regulator-1 predicts poor prognosis for patients with hepatocellular carcinoma after curative hepatectomy.
Wang C; Xiang H; Si H; Guo D; Sun M
Int J Clin Exp Pathol; 2015; 8(11):14818-23. PubMed ID: 26823810
[TBL] [Abstract][Full Text] [Related]
37. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
38. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
[TBL] [Abstract][Full Text] [Related]
39. SSR2 overexpression associates with tumorigenesis and metastasis of Hepatocellular Carcinoma through modulating EMT.
Hong X; Luo H; Zhu G; Guan X; Jia Y; Yu H; Lv X; Yu T; Lan H; Zhang Q; Li H; Sun W; Huang X; Li J
J Cancer; 2020; 11(19):5578-5587. PubMed ID: 32913453
[No Abstract] [Full Text] [Related]
40. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
